Achieve Life (ACHV) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ACHV Achieve Life

Watchlist

4.510
+0.220+5.13%

Close Nov 25 16:00 ET

4.400
-0.110-2.44%

Post 17:03 ET

155.10MMarket Cap-4026P/E (TTM)

Post-Market

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences
Achieve LifeNov 14 08:30 ET
This Turning Point Brands Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
BenzingaNov 14 07:53 ET
Rodman & Renshaw Initiates Achieve Life(ACHV.US) With Buy Rating, Announces Target Price $12
Moomoo NewsNov 14 07:31 ET · Ratings
Express News | Rodman & Renshaw Initiates Coverage On Achieve Life Sciences With Buy Rating, Announces Price Target of $12
BenzingaNov 14 07:03 ET
JonesTrading Maintains Achieve Life(ACHV.US) With Buy Rating, Maintains Target Price $20
Moomoo NewsNov 11 09:31 ET · Ratings
Achieve Life Sciences Poised for U.S. Launch of Cytisinicline With Strong Financial and Strategic Foundations
TipRanksNov 11 09:05 ET

Comments

MindOverMatter

Aug 13 19:03

$Achieve Life (ACHV.US)$

Jaguar8

May 29 07:01

NEWS

$Achieve Life (ACHV.US)$
Achieve Life Sciences Announces Initiation of ORCA-OL Clinical Trial Evaluating Long-Term Exposure of Cytisinicline in People who Smoke or Use Nicotine E-Cigarettes
Achieve Life Sciences has initiated the ORCA-OL clinical trial to evaluate the long-term safety of cytisinicline, a treatment for smoking and nicotine dependence. The open-label trial involves 29 U.S. sites and aims to collect data required for a New Drug Application (NDA) submission expected in the first ...